Korro Bio, Inc.
US ˙ NasdaqCM ˙ US5009461089

SecurityKRRO / Korro Bio, Inc.
InstitutionMorgan Stanley
Latest Disclosed Ownership41,123 shares
Latest Disclosed Value $ 465,512
Morgan Stanley reports 41.02% decrease in ownership of KRRO / Korro Bio, Inc.

On May 15, 2026 - Morgan Stanley filed a 13F-HR form disclosing ownership of 41,123 shares of Korro Bio, Inc. (US:KRRO) valued at $465,512 USD as of March 31, 2026. The entity filed a previous 13F-HR/A on May 27, 2026 disclosing 69,728 shares of Korro Bio, Inc.. This represents a change in shares of -41.02% during the quarter. The current value of the position is $455,643 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F KORRO BIO COM 500946108 41,123 -28,605 -41.02 466 -16.67 0.0000
2026-05-27 2025-12-31 13F/A-1 KORRO BIO COM 500946108 69,728 -97,766 -58.37 559 -93.04 0.0000
2026-02-13 2025-12-31 13F KORRO BIO COM 500946108 69,728 -97,766 559 0.0000
2026-05-27 2025-09-30 13F/A-1 KORRO BIO COM 500946108 167,494 85,761 104.93 8,021 686.37 0.0005
2025-11-14 2025-09-30 13F KORRO BIO COM 500946108 167,494 85,761 8,021 0.0005
2025-08-15 2025-06-30 13F KORRO BIO COM 500946108 81,733 38,633 89.64 1,021 36.00 0.0001
2025-05-15 2025-03-31 13F KORRO BIO COM 500946108 43,100 14,538 50.90 750 -31.00 0.0001
2025-05-15 2024-12-31 13F/A-1 KORRO BIO COM 500946108 28,562 5,207 22.30 1,087 39.36 0.0001
2025-02-14 2024-12-31 13F KORRO BIO COM 500946108 28,562 5,207 1,087 0.0001
2025-05-14 2024-09-30 13F/A-2 KORRO BIO COM 500946108 23,355 10,334 79.36 781 76.87 0.0001
2025-02-14 2024-09-30 13F/A-1 KORRO BIO COM 500946108 23,355 10,334 781 0.0001
2024-11-14 2024-09-30 13F KORRO BIO COM 500946108 23,355 10,334 781 0.0000
2025-05-14 2024-06-30 13F/A-2 KORRO BIO COM 500946108 13,021 5,352 69.79 441 -36.09 0.0000
2024-10-17 2024-06-30 13F/A-1 KORRO BIO COM 500946108 13,021 5,352 441 0.0000
2024-08-14 2024-06-30 13F KORRO BIO COM 500946108 13,021 5,352 441 0.0000
2024-10-17 2024-03-31 13F/A-2 KORRO BIO COM 500946108 7,669 1,701 28.50 690 141.26 0.0001
2024-08-16 2024-03-31 13F/A-1 KORRO BIO COM 500946108 7,669 1,701 690 0.0000
2024-05-15 2024-03-31 13F KORRO BIO COM 500946108 7,669 1,701 690 0.0001
2024-08-16 2023-12-31 13F/A-1 KORRO BIO COM 500946108 5,968 5,968 286 0.0000
2024-02-13 2023-12-31 13F KORRO BIO COM 500946108 5,968 5,968 286 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.